Resona Asset Management Co. Ltd. Reduces Stake in HCA Healthcare, Inc. $HCA

Resona Asset Management Co. Ltd. decreased its stake in HCA Healthcare, Inc. (NYSE:HCA) by 6.4% in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 59,014 shares of the company’s stock after selling 4,024 shares during the quarter. Resona Asset Management Co. Ltd.’s holdings in HCA Healthcare were worth $25,100,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Park Place Capital Corp lifted its position in shares of HCA Healthcare by 2,336.0% during the second quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock worth $474,000 after purchasing an additional 1,168 shares during the last quarter. Cerity Partners LLC boosted its position in HCA Healthcare by 13.1% in the 3rd quarter. Cerity Partners LLC now owns 43,920 shares of the company’s stock valued at $18,719,000 after buying an additional 5,092 shares during the period. Swiss National Bank increased its position in shares of HCA Healthcare by 4.3% during the second quarter. Swiss National Bank now owns 558,900 shares of the company’s stock worth $214,115,000 after acquiring an additional 23,100 shares during the period. Cherokee Insurance Co bought a new position in HCA Healthcare in the second quarter worth approximately $3,869,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al grew its position in shares of HCA Healthcare by 4.2% during the 3rd quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 297,300 shares of the company’s stock worth $126,709,000 after buying an additional 11,900 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently commented on HCA shares. Cantor Fitzgerald restated an “overweight” rating on shares of HCA Healthcare in a report on Monday, October 27th. Morgan Stanley lowered HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 target price for the company. in a report on Monday, December 15th. Wells Fargo & Company boosted their price target on HCA Healthcare from $431.00 to $452.00 and gave the stock an “equal weight” rating in a research report on Wednesday, January 7th. TD Cowen reiterated a “buy” rating on shares of HCA Healthcare in a research note on Monday, October 27th. Finally, Jefferies Financial Group raised their price target on shares of HCA Healthcare from $525.00 to $535.00 and gave the company a “buy” rating in a report on Thursday. Fourteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $488.75.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the transaction, the executive vice president directly owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. This represents a 52.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $470.52 on Friday. The firm has a market capitalization of $107.37 billion, a price-to-earnings ratio of 18.19, a PEG ratio of 1.30 and a beta of 1.36. The stock’s 50-day simple moving average is $480.37 and its 200-day simple moving average is $433.92. HCA Healthcare, Inc. has a fifty-two week low of $295.00 and a fifty-two week high of $520.00.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. The business had revenue of $19.16 billion for the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. HCA Healthcare’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $4.90 EPS. As a group, equities analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.